Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
May and Kumar1 conclude that “cyclizine should be avoided in patients with acute coronary events”, although we note that the BETs online version states “there appears to be no firm evidence that cyclizine increases morbidity and mortality in patients with myocardial ischaemia”. They reviewed a single 16–year–old study, which looked at a small number of patients suffering from heart …
Competing interests: None declared.